Bayer HealthCare, MEDRAD Europe B.V.

P.O. Box 205
6190 AE Beek

Tel: +31 43 3585 600


digestive tract

Aspirin linked to reduction in risk of several cancers

Aspirin is associated with a reduction in the risk of developing several cancers of the digestive tract, including some that are almost invariably fatal, such as pancreatic and liver cancers.


Bayer in cancer collaboration

Finnish pharma company Orion and German healthcare giant Bayer have entered into an agreement for the development and commercialisation of a novel drug targeting prostate cancer.


Bayer to divest Interventional device business for $415 million

Bayer HealthCare has entered into a definitive agreement to sell its Interventional device business to Boston Scientific for $415 million (about EUR 300 million), including fees for transitional…


Move to significantly strengthen position in consumer care

Bayer has agreed to acquire the consumer care business of U.S. pharmaceutical company Merck & Co., Inc., Whitehouse Station, NJ, USA, for a purchase price of USD 14.2 billion (EUR 10.4 billion).


"Excellence across Borders" fosters practical diabetes management

Bayer HealthCare supports local projects under the "Excellence across Borders" program in order to improve care of people with diabetes. Among the projects is a Diabetic School Awareness…


German Cancer Research Center to broaden strategic alliance with Bayer HealthCare

The German Cancer Research Center (DKFZ) and Bayer HealthCare (Bayer) will extend their successful strategic research alliance in search of novel cancer therapeutics by focusing their activities also…


Wound healing

Modern wound management can shorten treatment and turn in-patient treatment into out-patient care, reducing time and costs. It’s all down to today’s more sophisticated materials.


Bayer to Present Data on Oncology Pipeline

Bayer HealthCare announced that the company will present preclinical data that introduce investigational compounds for both therapy and imaging in its early oncology pipeline with unique and novel…


Self-monitoring of blood glucose

Around 75% of adult type 1 and type 2 diabetics say they believe they know what their blood sugar levels are, without testing, according to data presented at the American Diabetes Association 70th…


Bayer Diabets launched DIDGET

Bayer Diabetes Care in the UK and Ireland has launched Didget, the first and only blood glucose meter for diabetic children that connects directly to Nintendo DS and DS Lite gaming systems.


Bayer presents positive Phase II data with florbetaben

Bayer Schering Pharma AG, Germany, has presented positive data on a global Phase II study with the novel positron emission tomography (PET) tracer florbetaben (BAY 94-9172) at the International…

Alzheimer disease: positive Phase II data with florbetaben

Bayer Schering Pharma AG, Germany, has presented positive data on a global Phase II study with the novel positron emission tomography (PET) tracer florbetaben (BAY94-9172) at the International…


Diabetes management

This April, scientists, physicians, nurses, diabetes organisation heads, patients and representatives from Bayer HealthCare Diabetes Care gathered in Basel, Switzerland, for the third European Media…

Growing up with diabetes

Diabetes presents a special challenge for the young. Here we see how a young
Swiss girl has successfully come to terms with her metabolic disorder. A true life story from Bayer HealthCare…


Xarelto gains EU approval

The European Commission has granted marketing approval to the Bayer Group for Xarelto (rivaroxaban), an anticoagulant taken as one tablet, once-daily, to prevent venous thrombo-embolic events (VTE)…

Products redesigned to help patients simplify life with diabetes

Bayer HealthCare Diabetes Care unveiled the new

CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of…


Bayer's new Contour meter and Microlet 2 devices

The new Contour blood glucose meter from Bayer HealthCare Diabetes Care promises enhanced testing features that can be personalised to meet diabetics individual treatments. The firm has also…


Two more cancer drug-candidates for Bayer Schering Pharma AG

Bayer Schering AG, Germany, acquires the preclinical anti-cancer program from Swiss pharma company Nycomed. Two potential drug candidates are expanding the German oncology pipeline.


Bayer HealthCare glucose monitoring system climbs the top

Bayer loves sports. Therefore it developes medical devices to work under extremes. Recently extrem-athlete and diabetic Geri Winkler conquered the Seven Summits - a group of mountains comprising the…

Developments in dressings and bedding

Little research has been carried out into new therapies for wound healing. As chronic wounds tend to be classed as side effects of other diseases, e.g. diabetes, they are often treated as trivial.…

New drug protects against venous blood clots

In the EU blood clots are responsible for killing 544.000 people each year. Rivaroxaban, a new oral given anticoagulant drug from Bayer Healthcare, is significantly more effective than the current…


New medical options by tobacco plants

Bayer and its affiliated firm Icon Genetics developed an own production process which provides the opportunity to make therapeutic proteins from tobacco plants. The pilot plant for biotech drugs…


Global perspectives on diabetes

Despite Hurricane Amma storming over Prague, hundreds of medical specialists paid little attention when they attended the 1st International Conference on Advanced Technologists and Treatments for…

Primovist shows positive results

Bayer Schering Pharma presented the latest data from a health-economic evaluation of Primovist in the diagnosis of liver metastases. The results indicate that MRI using the liver-cell-specific…


A novel PET tracer for early detection of Alzheimers

Amyloidb (Ab) plaque formation is a hallmark of Alzheimers disease (AD) and precedes the onset of dementia. Australian researchers reported the first data on the validity in humans of a new PET…


Merger Agreement between MEDRAD and Possis Medical

As announced today, MEDRAD, an affiliate of Bayer HealthCare and a leading provider of contrast injection systems used to diagnose cardiovascular disease, has entered into a definitive merger…


Wireless blood glucose testing arrives

The first wireless POC (Point of care) blood glucose and bedside testing solution for hospitals was launched by Bayer Healthcare during the 43rd Annual Meeting of the European Association for the…


First approved blood pool contrast agent

Gadofosveset trisodium (trade name: Vasovist) is the first approved blood pool contrast agent worldwide for the diagnosis of vascular disease, Bayer Schering Pharma AG reports.


Antibiotics for Africa and Latin America

A donation of the antibiotic Cipro® (Bayer HealthCare) with a wholesale value of more than US$ 25 million has been given to the non-profit organization MAP (Medical Assistance Programs) who will…


Automated analyses

Advia LabCell Modular Automation Systems integrate clinical chemistry, immunodiagnostics, haematology, urinalysis, and other hospital and laboratory areas.


Siemens to acquire Bayer's Diagnostics Division

Siemens has signed an agreement with Bayer to acquire the chemical and pharmaceutical company's Diagnostics Division.